Skip to content



Tumor Marker Test. NGS Genetic Testing for Cancer with PositiveSelect Plus.

560 genes 1000x coverage.

Chemotherapy | Targeted Therapy | Immunotherapy

560 Genes at 1000x Coverage

Comprehensive genomic profiling with industry-leading 1000x coverage.  

Block or Blood

The test can be performed on liquid biopsy (blood tests) or tests tumor (FFPE).

NGS Test for Cancer

NGS Test is recommended for difficult to treat cancers, aggressive cancers, rare cancers and first line failures.

Multiple Treatment Options

Report will give treatment options including Chemotherapy, Targeted therapy  and Immunotherapy.


Advanced Tumor Marker Testing

The test includes Microsatellite Instability (MSI) and Tumor Mutation Burden (TMB) testing on a 560 gene panel which provides accurate indication for immunotherapy options.

For the most accurate TMB calculation at least 300 genes must be tested*

Our brochure explains in detail the benefits of the test as well as what is included.

Detailed and Informative Report

Your report will include:

  • Personalised treatment plan
  • MSI and TBM
  • Clinically actionable mutations

This test is applicable for most cancer types including endometrial cancer, lymph node cancer. The test can be taken with a blood test allowing patients of all ages to use this test. Test results help doctors decide personalised treatment option. 

This genetic test for cancer is run with Next Generation Sequencing (NGS testing) technology. 



Buy PositiveSelect Plus

Comprehensive Testing. Comprehendible Results.

Order Test Now

PositiveSelect Plus, NGS genetic test for cancer, that provides inclusive results by testing 560 genes with industry leading standards. The tumor marker test report will give you treatment options for chemotherapy, targeted therapy and immunotherapy.

Our experts and doctors are happy to guide you.